Several studies have demonstrated the cobas EGFR mutation test v2 to be superior over other qPCR-based tests in molecular analysis of EGFR mutations in tumor tissue [22,23,24] and liquid biopsy [25,26,27,28]. This evidence concerns the gene EGFR and neoplasm.